While the trials are taking longer than originally expected,...

While the trials are taking longer than originally expected, probably because of the heightened need for data sets flowing from our AI collaborations with Nvidia and Keysight, the gains in the capacity of the tech - as you have clearly elaborated - make the delays more than worthwhile. Scott's team are well on the way to establishing best of breed solutions in their key (very large) potential markets.

Patience will be well rewarded here IMO. In a year from now we should have - or be close to having the validation trial outcomes (given that the date of last anticipated recruit enrolment is scheduled for 28 Feb 25 and the date of last data collection is scheduled for 28 Mar 25). If the outcomes are excellent the pathways through regulation and commercialisation for EMU should be relatively straightforward - with first commercial sales in late calendar 25/early 2026 a real possibility.

The 50 months I have been invested in EMvision have gone relatively quickly with so much achieved. The next 20 months will be a fun - albeit slow burn - ride.